Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 5, 2011
Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirinRenato Bonardi, Marco Tabone, Aldo Manca, et al.
Research in Sports Medicine (Print)|February 22, 2025
Injury risk profile for soccer players: identification of the risk factors for soccer-related injuries - an umbrella reviewFederico Genovesi, Marco Tabone, Stefano Nuara, et al.
International Journal of Sports Medicine|June 23, 2025
Practical Guidelines for Athlete's Injury and Illness Surveillance: A Narrative ReviewFederico Genovesi, Tindaro Bongiovanni, Elena Pasquali, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Downstaging unresectable hepatocellular carcinoma by radioembolization using 90-yttrium resin microspheres: a single center experienceMarco Tabone, Amedeo Calvo, Nadia Russolillo, et al.
European Journal of Gastroenterology & Hepatology|December 7, 2002
Re-treatment with interferon-beta of patients with chronic hepatitis C virus infectionRinaldo Pellicano, Franco Palmas, Giuseppe Cariti, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 14, 2019
PET-CT post therapy dosimetry in radioembolization with resin <sup>90</sup>Y microspheres: Comparison with pre-treatment SPECT-CT <sup>99m</sup>Tc-MAA resultsElisa Richetta, Massimo Pasquino, Matteo Poli, et al.
Journal of Digestive Diseases|June 30, 2021
Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysisCarolina Martelletti, Andrea Ricotti, Marcantonio Gesualdo, et al.
Journal of Hepatology|May 5, 2004
Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trialsAlessandra Mangia, Gioacchino Leandro, Beat Helbling, et al.
Hepatology (Baltimore, Md.)|September 26, 2002
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapyGiorgio Saracco, Alda Olivero, Alessia Ciancio, et al.
Pageof 1